US5252557A — Administration method of antithrombin

Claim 1

Independent Claim 144 words

A surgical method, comprising the following steps: (a) performing intracorporeal surgery to a region of a mammal by dissecting the mammal's skin to expose tissue; (b) administering an antithrombin solution, including antithrombin at a concentration of more than 0.5 U/ml and not more than 250 U/ml and sodium hyaluronate having an average molecular weight between 50,000 and 13,000,000 with a weight concentration of at least 0.1% and not more than 3% dissolved in a physiological buffer solution, to the surgery region by coating the exposed tissue of the internal surgical region with the solution, wherein viscosity and elasticity of the solution is maintained through inhibition of fibrin formation with the antithrombin as fibrin binds to the sodium hyaluronate, thus inhibiting postoperative adhesion of the surgically traumatized organs; and (c) closing the surgery region without the removal of the antithrombin solution from the surgical region.

Claim 2

Dependent Claim 144 words

A surgical method, comprising the following steps: (a) performing intracorporeal surgery to a region of a mammal by dissecting the mammal's skin to expose tissue; (b) administering an antithrombin solution, including antithrombin at a concentration of more than 0.5 U/ml and not more than 250 U/ml and sodium hyaluronate having an average molecular weight between 50,000 and 13,000,000 with a weight concentration of at least 0.1% and not more than 3% dissolved in a physiological buffer solution, to the surgery region by coating the exposed tissue of the internal surgical region with the solution, wherein viscosity and elasticity of the solution is maintained through inhibition of fibrin formation with the antithrombin as fibrin binds to the sodium hyaluronate, thus inhibiting postoperative adhesion of the surgically traumatized organs; and (c) closing the surgery region without the removal of the antithrombin solution from the surgical region.

Claim 3

Dependent Claim 22 words

The method as claimed in claim 1, wherein step (a) comprises the step of performing surgery on a joint including synovial fluid.

Claim 4

Dependent Claim 38 words

The method as recited in claim 2, wherein step (b) further comprises replacing a portion of the synovial fluid of the joint with the antithrombin solution to maintain viscosity and elasticity of the synovial fluid after step (c).

Claim 5

Dependent Claim 35 words

The method as claimed in claim 2, wherein step (b) further comprises adding the antithrombin solution to the synovial fluid of the joint to maintain viscosity and elasticity of the synovial fluid after step (c).

Claim 6

Dependent Claim 88 words

A therapeutic method comprising the step of administering to mammals intrasynovially by injection an antithrombin solution to maintain viscosity and elasticity of synovial fluid by inhibiting fibrin formation with antithrombin as fibrin binds to sodium hyaluronate, whereby said solution includes antithrombin with a concentration of more than 0.5 U/ml and not more than 250 U/ml and sodium hyaluronate having an average molecular weight between 350,000 and 8,000,000 with a weight concentration of at least 0.1% and not more than 3%, which are dissolved in a physiological buffer solution.

Claim 7

Dependent Claim 88 words

A therapeutic method comprising the step of administering to mammals intrasynovially by injection an antithrombin solution to maintain viscosity and elasticity of synovial fluid by inhibiting fibrin formation with antithrombin as fibrin binds to sodium hyaluronate, whereby said solution includes antithrombin with a concentration of more than 0.5 U/ml and not more than 250 U/ml and sodium hyaluronate having an average molecular weight between 350,000 and 8,000,000 with a weight concentration of at least 0.1% and not more than 3%, which are dissolved in a physiological buffer solution.

Claim 8

Dependent Claim 18 words

The method of claim 5, further comprising the substep of adding sodium chondroitin sulfate to the antithrombin solution.

Claim 9

Dependent Claim 113 words

A surgical method for mammals, comprising the following steps; (a) performing intracorporeal surgery to a region by dissecting skin to expose tissue; (b) administering a solution, including antithrombin at a concentration of more than 0.5 U/ml and not more than 250 U/ml and a viscous substance which are dissolved in a physiological buffer solution, to the surgery region by coating the exposed tissue with the solution, wherein viscosity and elasticity of the solution is maintained through inhibition of fibrin formation with the antithrombin as fibrin binds to the viscous substance, thus inhibiting postoperative adhesion of the surgically traumatized organs; and (c) closing the surgery without removal of the solution from the surgical region.

Claim 10

Dependent Claim 113 words

A surgical method for mammals, comprising the following steps; (a) performing intracorporeal surgery to a region by dissecting skin to expose tissue; (b) administering a solution, including antithrombin at a concentration of more than 0.5 U/ml and not more than 250 U/ml and a viscous substance which are dissolved in a physiological buffer solution, to the surgery region by coating the exposed tissue with the solution, wherein viscosity and elasticity of the solution is maintained through inhibition of fibrin formation with the antithrombin as fibrin binds to the viscous substance, thus inhibiting postoperative adhesion of the surgically traumatized organs; and (c) closing the surgery without removal of the solution from the surgical region.

Claim 11

Dependent Claim 24 words

The method as claimed in claim 7, wherein the viscous substance is selected from the group sodium chrondroitin sulfate, hydroxypropylmethylcellulose, polyacrylamide and collagen type-IV.

Claim 12

Dependent Claim 109 words

A surgical method for mammals, comprising the following steps; (a) performing intracorporeal surgery to a region by dissecting the skin to expose tissue; (b) adminstering a solution, including antithrombin at a concentration of more than 0.5 U/ml and not more than 250 U/ml which is dissolved in a physiological buffer solution, to the surgery region where a viscous substance is used, wherein viscosity and elasticity of the viscous substance is maintained by inhibiting fibrin formation with the antithrombin as fibrin binds to the viscous substance, thus inhibiting postoperative adhesion of the surgically traumatized organs; and (c) closing the surgery without removal of the antithrombin solution from the surgical region.

Claim 13

Dependent Claim 109 words

A surgical method for mammals, comprising the following steps; (a) performing intracorporeal surgery to a region by dissecting the skin to expose tissue; (b) adminstering a solution, including antithrombin at a concentration of more than 0.5 U/ml and not more than 250 U/ml which is dissolved in a physiological buffer solution, to the surgery region where a viscous substance is used, wherein viscosity and elasticity of the viscous substance is maintained by inhibiting fibrin formation with the antithrombin as fibrin binds to the viscous substance, thus inhibiting postoperative adhesion of the surgically traumatized organs; and (c) closing the surgery without removal of the antithrombin solution from the surgical region.

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	1996-10-11	1997-04-12	1997-10-12	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	2000-10-11	2001-04-12	2001-10-12	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	2004-10-11	2005-04-12	2005-10-12	$7700.00	Window Closed / Lapsed

Administration method of antithrombin

Abstract

Inventors

Bibliographic Details

Claims Analysis

References Cited (Backward Citations)

USPTO Annuity & Maintenance Windows

Assigned Categories & Tags

Assign Category Tag